Skip to main content
. Author manuscript; available in PMC: 2009 Oct 15.
Published in final edited form as: Biochem Pharmacol. 2009 Jun 21;78(8):959–965. doi: 10.1016/j.bcp.2009.06.019

Fig. 6.

Fig. 6

Exposure of endothelial cells to PCB 104 dose-dependently reduced cell viability, an effect attenuated by inhibition of CYP1A1 and PARP either pharmacologically or through gene deletion. Data is expressed as mean ± SEM from 4 separate experiments with 3–6 replicates per experiment; *p < 0.05, **p < 0.01 vs. untreated cells and †p < 0.01 vs. PCB 104 treated cells.